Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy
暂无分享,去创建一个
M. Nowak | D. Ho | Y. Cao | S. Rowland-Jones | D. Nixon | X. Jin | S. Bonhoeffer | A. Hurley | M. Markowitz | Xia Jin | G. Ogg | A. McMichael | P. Moss | Yun-zhen Cao | S. Monard | J. Segal | A. J. McMichael | M. A. Nowak | Y. Cao | M. Markowitz | G. S. Ogg | X. Jin | S. Bonhoeffer | P. Moss | S. Monard | J. P. Segal | S. L. Rowland-Jones | A. Hurley | D. D. Ho | D. F. Nixon | Y. Cao | Sebastian Bonhoeffer | Andrew J. McMichael | Martin A. Nowak | Graham S. Ogg | Sarah L. Rowland-Jones | Douglas F. Nixon | Paul Moss | David D. Ho | Simon Monard | Jeremy P. Segal | Graham S Ogg | A. J. McMichael
[1] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[2] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[3] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[4] D. Cooper,et al. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. , 1996, The Journal of infectious diseases.
[5] B. Walker,et al. An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Rowland-Jones,et al. Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 , 1999, Journal of Virology.
[7] David Gray,et al. Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.
[8] D. Nixon,et al. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. , 1990, International immunology.
[9] D. Ho,et al. Toward HIV eradication or remission: the tasks ahead. , 1998, Science.
[10] Kiyoshi Miwa,et al. Identification of multiple HIV‐1 cytotoxic T‐cell epitopes presented by human leukocyte antigen B35 molecules , 1996, AIDS.
[11] K. Parker,et al. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. , 1992, Journal of immunology.
[12] R. Phillips,et al. Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation , 1997, The Journal of experimental medicine.
[13] S. Rowland-Jones,et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[15] D. Cooper,et al. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[16] S. Rowland-Jones,et al. Distinct Recognition of Non-Clade B Human Immunodeficiency Virus Type 1 Epitopes by Cytotoxic T Lymphocytes Generated from Donors Infected in Africa , 1999, Journal of Virology.
[17] J Leibowitch,et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.
[18] S. Rowland-Jones,et al. Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific , 1998, The Journal of experimental medicine.
[19] P. Klenerman,et al. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro , 1997, European journal of immunology.
[20] G Shubinsky,et al. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. , 1997, Immunity.
[21] R. Detels,et al. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.
[22] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.